RBC Positive on Sarepta Therapeutics (SRPT) Into Tomorrow's R&D Day
Tweet
Share
E-mail
Get Alerts SRPT Hot Sheet
Price: $19.22 -2.58%
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
RBC Capital analsyt Brian Abrahams notes the agenda for Sarepta Therapeutics (NASDAQ: SRPT) R&D Day tomorrow was just made available here.
The analsyt continues to like the prospects for microdystrophin data, which will be presented at 9:20am ET.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citigroup set to join top banks in Anthropic IPO - Bloomberg
- Jefferies Downgrades Sunway Healthcare Holdings (SUNMED:MK) to Hold
- Walmart (WMT) PT Lowered to $126 at BofA Securities
Create E-mail Alert Related Categories
Analyst Comments, FDA, Trader TalkRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
